Let's Talk Science. Let's Talk Medicine. The leading scientific social networking website and producer of educational virtual events and webinars.

More doctors are ordering bioAffinity Technologies' CyPath Lung test and sales are skyrocketing. A long-term military health ...

As the global flow cytometry market continues to evolve, it presents a wealth of opportunities for innovation and investment.

Unlike chimeric antigen receptor (CAR) T-cell therapies, which can identify surface antigens, TCR-T cell therapies like ...

Ferroptosis, a distinctive modality of cell mortality, has emerged as a critical regulator in non-small cell lung cancer (NSCLC). The deubiquitinating enzyme USP5 has established an oncogenic role in ...

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia ...

Affinity Technologies' CyPath® Lung test will be added to the Federal Supply Schedule to help veterans and active military at ...

HBI0101, an academically sourced CAR T-cell therapy, demonstrated a high objective response rate and manageable safety in ...

Their findings show that targeting tumors in different ways simultaneously ... Scientific Computing, Flow Cytometry, Cell Services and Biological Resources teams at the Crick.

Researchers at Medicine have uncovered a new mechanism that controls a special group of immune cells known as regulatory ...

CUT-Tag is used to identify super-enhancers (SEs) for the first time in gastric cancer, and the mRNA decay mechanism activated by SE-driven ZFP36L1 in infiltrative gastric cancer along with innovative ...

Affinity Technologies has appointed J. Michael Edwards as Chief Financial Officer. Takeaway Points bioAffinity Technologies ...